CClinicalTrials.gg
TerminatedNCT01313026Updated Dec 7, 2018

Treatment of "Low Anterior Resection Syndrome" by Percutaneous Nerve Evaluation and Transanal Irrigation

An interventional study of Percutaneous nerve evaluation in Rectal Cancer, sponsored by University of Aarhus. Terminated at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-12-07.

Sponsored by University of Aarhus · Not applicable, Interventional, and Treatment

Why this study was terminated
Difficult to recruit participants
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A randomised trial testing the effect of percutaneous nerve evaluation and transanal irrigation on bowel function in patients after low anterior resection for rectal cancer.

Read the detailed description

Patients will undergo anal physiological assessment and will then be randomized to either treatment arm. The first 12 weeks they will be optimized in the conservative treatment of their bowel function before beginning active treatment with TAI or PNE. After 8 and 4 weeks respectively, the treatment will stop and they will have a period of 4 weeks back on optimized conservative treatment before beginning active treatment in the other active arm.

Detailed records of bowel, micturition and sexual function and QoL will be obtained at regular intervals during the entire trial fase.

02

Conditions studied

  • Rectal Cancer

Keywords

  • Percutaneous nerve evaluation
  • Transanal irrigation
  • Low anterior resection syndrome
03

In context

Low Anterior Resection Syndrome

85 studies on the registry are indexed under Low Anterior Resection Syndrome; 36 are open to participants now.

This study's enrollment of 14 is below the median of 67 across 57 interventional studies indexed under Low Anterior Resection Syndrome.

Browse Low Anterior Resection Syndrome studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Low anterior resection for rectal cancer between May 2001 and May 2011

Exclusion criteria

Exclusion Criteria:

  • Non-radical resection
  • metastatic disease
  • Chemotherapy
  • Radiotherapy
  • Previously treated for another cancer
  • Dementia or other mental retardation/severe mental disease
  • Inability to read and understand the Danish language
  • Recurrent disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Active comparator
    PNE first

    patients randomised to start with PNE stimulation over 4 weeks. Then the stimulator will be removed and after a wash out period of 4 weeks they will be trained in transanal irrigation

    Procedure: Percutaneous nerve evaluation

  • Active comparator
    TAI first

    Patients randomised to start with transanal irrigation treatment in 8 weeks, thereafter a wash out period of 4 weeks before being implanted with a neuro stimulator

    Procedure: Percutaneous nerve evaluation

Interventions

  • ProcedurePercutaneous nerve evaluation

    Implantation of a nerve stimulator to stimulate the sacral nerve plexus

    Also known as: The Peristeen Anal Irrigation System, Medtronic nerve stimulators

06

What researchers measure

Primary outcomes

  1. changes in LARS score

    A symptom score ranging from 0 to 42 points calculated on the basis of bowel function

    Time frame: baseline, 12, 16, 20, 24 and 28 weeks

Secondary outcomes

  1. Sexual function

    self-reported sexual function measured by validated questionnaires

    Time frame: baseline, 12, 16, 20, 24 and 28 weeks

  2. Bladder function

    self-reported bladder function by validated questionnaires

    Time frame: baseline, 12, 16, 20, 24 and 28 weeks

  3. Incontinence

    faecal incontinence measured by wexner score and St. Marks incontinence score

    Time frame: baseline, 12, 16, 20, 24 and 28 weeks

  4. Patient Satisfaction

    patient satisfaction measured on a VAS

    Time frame: baseline, 12, 16, 20, 24 and 28 weeks

07

Study locations

1 site
  • Colorectal Surgical Department P, Aarhus University Hospital
    Aarhus, 8000, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01313026
Lead sponsor
University of Aarhus
Responsible party
Sponsor
First posted
Mar 11, 2011
Start date
Jan 2011
Primary completion
Feb 2018
Completion
Sep 2018
Last update
Dec 7, 2018

Study contacts

Katrine J. Emmertsen, MD
principal investigator · University of Aarhus

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion